Compare COEP & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COEP | FSI |
|---|---|---|
| Founded | 2017 | 1991 |
| Country | United States | Canada |
| Employees | 7 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 67.8M |
| IPO Year | N/A | 2000 |
| Metric | COEP | FSI |
|---|---|---|
| Price | $11.95 | $5.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 35.4K | 13.4K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $15,494,325.00 |
| Revenue This Year | N/A | $4.11 |
| Revenue Next Year | N/A | $58.09 |
| P/E Ratio | ★ N/A | $59.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.32 | $3.46 |
| 52 Week High | $21.41 | $11.48 |
| Indicator | COEP | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 48.18 |
| Support Level | $10.65 | $5.21 |
| Resistance Level | $13.23 | $5.47 |
| Average True Range (ATR) | 0.89 | 0.22 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 64.72 | 37.73 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.